Promote Sponsor
verified SJR 2,988 · Q1 • database Scopus / SJR & Web of Science indexed
Movement Disorders
United States · John Wiley & Sons Inc.
workspace_premium Q1 — Neurology (clinical) lock_open Open Access Unclaimed

Movement Disorders

Movement Disorders is a journal indexed in SJR in Neurology (clinical) and Neurology with an H index of 238. It has a price of 2500 €. It has an SJR impact factor of 2,988 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 2,988.

Movement Disorders focuses its scope in these topics and keywords: parkinsons, disease, study, stimulation, patients, parkinsonian, trial, early, clinical, randomized, ...

ISSN: 0885-3185
Editorial: John Wiley & Sons Inc.
Category: Neurology (clinical)
Indexation: verifiedScopus / SJR verifiedWeb of Science

Unclaimed profile — some fields may be incomplete.

open_in_new Portal NPD menu_book Guidelines NPD
schedule Datos CoP · solo campos en BD
SJR Impact Factor trending_up
2,988 Q1
H-index 238
Tasa de Aceptación pie_chart
19% Selectiva
Fuente Acceptance_Rate
Tiempo a publicación hourglass_top
NPD
Campo Sin dato
Coste de Publicación (APC) payments
2.500 € Open Access
Ruta Non-OA 0 €

Metrics

Campos Scimago / CoP — sin series inventadas

Scopus / SJR Web of Science

SJR Impact

2,988

H-index

238

Docs (year)

337

Docs 3y

1169

Total refs

11454

Cites 3y

6168

Citable 3y

768

Cites/Doc 2y

5.1

Ref/Doc

33.99

Immediate OA

2500 €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Botulinum toxin in neuro-urological disorders

View more

Wide expressivity variation and high but no gender-related penetrance in two dopa-responsive dystonia families with a novel GCH-I mutation

View more

Clinical signs and symptoms in a large hereditary spastic paraparesis pedigree with a novel spastin mutation

View more

Clinical heterogeneity of neurodegeneration with brain iron accumulation (Hallervorden-Spatz syndrome) and pantothenate kinase-associated neurodegeneration

View more

Clinical characteristics of Parkinson's disease among Inuit in Greenland and inhabitants of the Faroe Islands and Als (Denmark)

View more

Clinical and genetic features of myoclonus-dystonia in 3 cases: A video presentation

View more

Chorea-acanthocytosis associated with tourettism

View more

Chorea and contraceptives: Case report with pet study and review of the literature

View more

Cerebrospinal fluid analysis for Whipple's disease in patients with progressive supranuclear palsy

View more

Cerebrospinal fluid Abeta42levels in multiple system atrophy

View more

Cardiovascular effects of methamphetamine in Parkinson's disease patients

View more

Cabergoline versus levodopa monotherapy

View more
SHOW MORE ARTICLES

Botulinum toxin treatment of secretory disorders

View more

"Mistaken diagnosis of psychogenic gait disorder in a man with status cataplecticus (""Limp Man Syndrome"")"

View more

Basic and therapeutic aspects of neurotonins

View more

Autosomal recessive juvenile parkinsonismCys212Tyr mutation in parkin renders lymphocytes susceptible to dopamine- and iron-mediated apoptosis

View more

Asymmetrical awake bruxism associated with multiple system atrophy

View more

Assessing quality of life in Parkinson's disease: Can a short-form questionnaire be useful?

View more

Assessing comorbidity in patients with Parkinson's disease

View more

Anxiety in musicians with focal dystonia and those with chronic pain

View more

Anomalies of asymmetry of clinical signs in parkinsonism

View more

Alteration in a-synuclein mRNA expression in Parkinson's disease

View more

Adverse effects of dopamine potentiation by long-term treatment with selegiline

View more

Accuracy of clinical diagnosis of progressive supranuclear palsy

View more

FAQS